Tilray Brands, Inc. is experiencing a positive movement today following the announcement that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with high-quality cannabis flowers. This tender, awarded by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg, underscores the trust placed in Tilray Medical's ability to deliver premium medical cannabis products. The news highlights Tilray's expanding presence in the European market, aligning with the growing demand for medical cannabis across the continent. Denise Faltischek, Chief Strategy Officer and Head of International, expressed pride in the selection, emphasizing the team's dedication to providing high-quality products globally.
The stock is currently trading at $1.46, reflecting a slight increase of 0.34% from the previous close of $1.45. Despite being just 30 minutes into the trading day, the stock has already seen a volume of 10,410,078 shares, representing 33.67% of the average daily volume of 30,914,453 shares, indicating heightened trading activity this morning.